CN115382476B - A method for preparing ultra-small particle size polymer nanoparticles - Google Patents
A method for preparing ultra-small particle size polymer nanoparticles Download PDFInfo
- Publication number
- CN115382476B CN115382476B CN202210883077.2A CN202210883077A CN115382476B CN 115382476 B CN115382476 B CN 115382476B CN 202210883077 A CN202210883077 A CN 202210883077A CN 115382476 B CN115382476 B CN 115382476B
- Authority
- CN
- China
- Prior art keywords
- solution
- polymer
- mixing
- particle size
- small particle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920000642 polymer Polymers 0.000 title claims abstract description 54
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 39
- 239000002245 particle Substances 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 14
- 238000002156 mixing Methods 0.000 claims abstract description 29
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000002904 solvent Substances 0.000 claims description 31
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 28
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 12
- 239000004065 semiconductor Substances 0.000 claims description 11
- 239000002243 precursor Substances 0.000 claims description 7
- 238000002390 rotary evaporation Methods 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 4
- -1 styrene-polyethylene Chemical group 0.000 claims description 4
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 230000012010 growth Effects 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- QPPJZINEHSIVEW-UHFFFAOYSA-N 4-(9,9-dioctylfluoren-2-yl)-2,1,3-benzothiadiazole Polymers C1=CC2=NSN=C2C(C2=CC=C3C4=CC=CC=C4C(C3=C2)(CCCCCCCC)CCCCCCCC)=C1 QPPJZINEHSIVEW-UHFFFAOYSA-N 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 108091006146 Channels Proteins 0.000 claims 4
- 102000004129 N-Type Calcium Channels Human genes 0.000 claims 2
- 108090000699 N-Type Calcium Channels Proteins 0.000 claims 2
- 239000012530 fluid Substances 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 8
- 239000007850 fluorescent dye Substances 0.000 abstract description 7
- 238000003786 synthesis reaction Methods 0.000 abstract description 7
- 238000006243 chemical reaction Methods 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 3
- 238000012377 drug delivery Methods 0.000 abstract description 2
- 238000005111 flow chemistry technique Methods 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 239000000969 carrier Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000520 microinjection Methods 0.000 abstract 1
- 239000010453 quartz Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 35
- 239000002096 quantum dot Substances 0.000 description 11
- 238000010586 diagram Methods 0.000 description 9
- 229920000109 alkoxy-substituted poly(p-phenylene vinylene) Polymers 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- 229910021642 ultra pure water Inorganic materials 0.000 description 6
- 239000012498 ultrapure water Substances 0.000 description 6
- 238000009826 distribution Methods 0.000 description 5
- 238000003917 TEM image Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 238000004627 transmission electron microscopy Methods 0.000 description 3
- 101000827703 Homo sapiens Polyphosphoinositide phosphatase Proteins 0.000 description 2
- 102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 2
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 2
- 239000008364 bulk solution Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000006911 nucleation Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000000935 solvent evaporation Methods 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 1
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 1
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000003486 chemical etching Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0093—Microreactors, e.g. miniaturised or microfabricated reactors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00002—Chemical plants
- B01J2219/00004—Scale aspects
- B01J2219/00011—Laboratory-scale plants
- B01J2219/00013—Miniplants
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00002—Chemical plants
- B01J2219/00027—Process aspects
- B01J2219/00029—Batch processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00788—Three-dimensional assemblies, i.e. the reactor comprising a form other than a stack of plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00819—Materials of construction
- B01J2219/00831—Glass
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00851—Additional features
- B01J2219/00858—Aspects relating to the size of the reactor
- B01J2219/00864—Channel sizes in the nanometer range, e.g. nanoreactors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00889—Mixing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E10/00—Energy generation through renewable energy sources
- Y02E10/50—Photovoltaic [PV] energy
- Y02E10/549—Organic PV cells
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nanotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Manufacturing & Machinery (AREA)
- General Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Abstract
本发明公开了一种超小粒径聚合物纳米颗粒的制备方法,涉及流动化学中使用微流控芯片进行纳米颗粒合成领域。本发明基于多通道微量注射泵和飞秒激光加工技术精细化刻制的三维通道微混合石英芯片构建了一个完整而简单的微反应体系,通过控制微混合芯片入口处的流速,可以合成重复性好、可持续大批量生产的超小粒径(<10 nm)聚合物纳米颗粒。合成的聚合物纳米颗粒可以作为靶向给药载体,荧光探针等,用于各类生物医学领域。
The present invention discloses a method for preparing ultra-small particle size polymer nanoparticles, and relates to the field of nanoparticle synthesis using microfluidic chips in flow chemistry. The present invention constructs a complete and simple micro-reaction system based on a multi-channel micro-injection pump and a three-dimensional channel micro-mixing quartz chip finely engraved by femtosecond laser processing technology. By controlling the flow rate at the inlet of the micro-mixing chip, ultra-small particle size (<10 nm) polymer nanoparticles with good repeatability and sustainable mass production can be synthesized. The synthesized polymer nanoparticles can be used as targeted drug delivery carriers, fluorescent probes, etc., and are used in various biomedical fields.
Description
技术领域Technical Field
本发明属于流动化学中使用微流控芯片进行纳米颗粒合成领域,具体涉及了一种在流动条件下通过微流控芯片室温可控合成不同种类的超小粒径聚合物纳米颗粒的方法。The invention belongs to the field of nanoparticle synthesis using a microfluidic chip in flow chemistry, and specifically relates to a method for synthesizing different types of ultra-small-diameter polymer nanoparticles in a room temperature controllable manner through a microfluidic chip under flow conditions.
背景技术Background Art
近年来,聚合物纳米颗粒(PNP)由于其小尺寸的特性引起了人们的极大兴趣。PNP作为药物载体的优势包括其潜在的控释用途,能够保护药物和其他具有生物活性的分子免受环境的破坏,提高其生物利用度和治疗指数。In recent years, polymeric nanoparticles (PNPs) have attracted great interest due to their small size. The advantages of PNPs as drug carriers include their potential for controlled release, their ability to protect drugs and other bioactive molecules from environmental damage, and their ability to improve their bioavailability and therapeutic index.
在常规合成方法中,聚合物纳米颗粒可以通过多种方式合成,例如纳米沉淀、溶剂蒸发、微乳液溶胶-凝胶、乳液聚合、逐层自组装、薄膜水化技术,乳化溶剂蒸发等。在 PNP合成中,三个步骤:成核、生长和团聚同时发生,没有很好的控制混合和分离则会导致PNP的尺寸分布发生变化。此外,合成批次的工业放大增加了混合和传质问题,因此无法很好的控制PNP的物理化学性质,如多分散性指数。In conventional synthesis methods, polymer nanoparticles can be synthesized in a variety of ways, such as nanoprecipitation, solvent evaporation, microemulsion sol-gel, emulsion polymerization, layer-by-layer self-assembly, thin film hydration technology, emulsified solvent evaporation, etc. In PNP synthesis, three steps: nucleation, growth and agglomeration occur simultaneously, and the size distribution of PNPs will change if mixing and separation are not well controlled. In addition, the industrial scale-up of the synthesis batch increases the mixing and mass transfer problems, so the physicochemical properties of PNPs, such as the polydispersity index, cannot be well controlled.
微流控平台在新一代 PNP 合成和药物递送应用方面引起了科学界的关注。特别是,与传统的 PNP 合成方法相比,新的连续流动微流体系统因其独特的特性而被广泛研究。在微流体系统中,PNP 形成的成核和生长步骤可以通过函数将它们分开,以获得对粒度和形态的绝对控制,从而增加合成批次的再现性。并且它可以大幅度地将溶剂和非溶剂的混合路径降低到几十微米,从而在几毫秒甚至微秒内通过扩散实现非常快的混合。此外,微流控系统通常在连续流中运行,能够持续控制产品的质量并实现批量生产。因此通过微流控系统制备尺寸分布均一、性能优良的聚合物纳米颗粒对探索该纳米材料的实际应用具有非常重要的意义。Microfluidic platforms have attracted scientific attention in the synthesis and drug delivery applications of the new generation of PNPs. In particular, the new continuous flow microfluidic system has been widely studied due to its unique characteristics compared with the traditional PNP synthesis method. In the microfluidic system, the nucleation and growth steps of PNP formation can be separated by functions to obtain absolute control over particle size and morphology, thereby increasing the reproducibility of the synthesis batch. And it can greatly reduce the mixing path of solvent and non-solvent to tens of microns, thereby achieving very fast mixing by diffusion within milliseconds or even microseconds. In addition, microfluidic systems usually operate in continuous flow, which can continuously control the quality of products and realize batch production. Therefore, the preparation of polymer nanoparticles with uniform size distribution and excellent performance through microfluidic systems is of great significance for exploring the practical application of this nanomaterial.
发明内容Summary of the invention
本发明的目的在于提供一种合成超小粒径、单分散性好的聚合物纳米颗粒的方法。The purpose of the present invention is to provide a method for synthesizing polymer nanoparticles with ultra-small particle size and good monodispersity.
实现本发明目的的具体技术方案是:The specific technical solution for achieving the purpose of the present invention is:
一种超小粒径聚合物纳米颗粒的制备方法,该方法包括以下具体步骤:A method for preparing ultra-small particle size polymer nanoparticles, the method comprising the following specific steps:
步骤1:将聚合物粉末溶解在良溶剂中,得聚合物良溶剂前驱体溶液A;Step 1: dissolving polymer powder in a good solvent to obtain a polymer good solvent precursor solution A;
步骤2:将前驱体溶液A按比例稀释,并加入两亲性试剂使其表面功能化,得溶液B;Step 2: dilute the precursor solution A in proportion, and add an amphiphilic reagent to functionalize its surface to obtain solution B;
步骤3:把溶液B和其不良溶剂C分别放置在注射泵上,将两相溶液注射至三维微流控混合芯片中,接着将混合后的液体流入烧瓶中;最后将烧瓶中的胶体溶液通过旋蒸除去良溶剂,干燥后得到所述超小粒径聚合物纳米颗粒;其中:Step 3: Place solution B and its poor solvent C on the syringe pumps respectively, inject the two-phase solution into the three-dimensional microfluidic mixing chip, and then flow the mixed liquid into the flask; finally, remove the good solvent from the colloidal solution in the flask by rotary evaporation, and obtain the ultra-small particle size polymer nanoparticles after drying; wherein:
所述良溶剂为四氢呋喃、丙酮、乙腈、N-N二甲基乙酰胺、二甲基亚砜(DMSO)、乙醇中的至少一种;所述不良溶剂为水;The good solvent is at least one of tetrahydrofuran, acetone, acetonitrile, N-N-dimethylacetamide, dimethyl sulfoxide (DMSO), and ethanol; the poor solvent is water;
所述聚合物是共轭半导体聚合物、聚乳酸- 羟基乙酸共聚物或聚乳酸;The polymer is a conjugated semiconductor polymer, a polylactic acid-co-glycolic acid polymer or polylactic acid;
所述良溶剂前驱体溶液A浓度为1mg/mL;所述溶液B中的聚合物溶液浓度为20-50ug/mL,其中聚合物溶液和两亲性试剂的浓度比为5-10∶1;The concentration of the good solvent precursor solution A is 1 mg/mL; the concentration of the polymer solution in the solution B is 20-50 ug/mL, wherein the concentration ratio of the polymer solution to the amphiphilic reagent is 5-10:1;
溶液B、不良溶剂C流速比为1∶1.5-3,溶液B流速为200-300 uL/min,不良溶剂C流速为300-600 uL/min;The flow rate ratio of solution B and poor solvent C is 1:1.5-3, the flow rate of solution B is 200-300 uL/min, and the flow rate of poor solvent C is 300-600 uL/min;
所述三维微流控混合芯片材质为石英玻璃。The three-dimensional microfluidic hybrid chip is made of quartz glass.
所述两亲性试剂是聚苯乙烯马来酸酐(PSMA)、聚苯乙烯(PS)和苯乙烯-聚乙二醇-羧基(PS-PEG-COOH)中任意一种。The amphiphilic agent is any one of polystyrene maleic anhydride (PSMA), polystyrene (PS) and styrene-polyethylene glycol-carboxyl (PS-PEG-COOH).
所述三维微流控混合芯片材质为石英玻璃,采用超快激光辅助化学腐蚀石英玻璃的技术制备而成。The three-dimensional microfluidic hybrid chip is made of quartz glass and is prepared by using ultrafast laser-assisted chemical etching of quartz glass.
所述共轭半导体聚合物为聚[(9,9-二辛基芴基-2,7-二基)-alt-(苯并[2,1,3]噻二唑-4,8-二基)](F8BT)、聚(9,9-二正辛基芴基-2,7-二基)(PFO)和聚[2-甲氧基-5-(2-乙基己氧基)-1,4-苯乙炔](MEH-PPV)。The conjugated semiconductor polymers are poly[(9,9-dioctylfluorenyl-2,7-diyl)-alt-(benzo[2,1,3]thiadiazole-4,8-diyl)] (F8BT), poly(9,9-di-n-octylfluorenyl-2,7-diyl) (PFO) and poly[2-methoxy-5-(2-ethylhexyloxy)-1,4-phenylethynyl] (MEH-PPV).
本发明采用三维微流控芯片成功制备聚合物纳米颗粒,相比于传统本体溶液中使用纳米沉淀法合成聚合物纳米颗粒,本发明采用微流控方法主要有以下优点:The present invention successfully prepares polymer nanoparticles using a three-dimensional microfluidic chip. Compared with the traditional method of synthesizing polymer nanoparticles using nanoprecipitation in bulk solution, the microfluidic method used in the present invention has the following advantages:
1)合成的聚合物纳米颗粒粒径均一、单分散性好,且大多材料合成后粒径小于10nm。远小于本体溶液合成的纳米颗粒粒径。1) The synthesized polymer nanoparticles have uniform particle size and good monodispersity, and most of the materials have a particle size less than 10nm after synthesis, which is much smaller than the particle size of nanoparticles synthesized from bulk solution.
2)不需要超声耗能过程,操作简单。2) No ultrasonic energy consumption process is required and the operation is simple.
3)利用飞秒激光加工技术精细化刻制微芯片三维通道,特定的三维混合方式使得其有着超高的混合效率。微流控芯片中的8个混合单元能够加速良溶剂与不良溶剂之间的混合程度。使其在纳米粒子聚集前完成混合,因而可以形成超小粒径的聚合物纳米颗粒。3) The three-dimensional channels of the microchip are finely engraved using femtosecond laser processing technology. The specific three-dimensional mixing method makes it have ultra-high mixing efficiency. The eight mixing units in the microfluidic chip can accelerate the mixing degree between the good solvent and the poor solvent. The mixing is completed before the nanoparticles aggregate, thus forming ultra-small particle size polymer nanoparticles.
4)与传统采用PDMS做的微流控芯片相比,本发明中的微流控芯片为玻璃材质,当有机溶剂通入后,不会使芯片产生溶胀。因此可以在通道内进行连续流反应,批量生产聚合物纳米颗粒。4) Compared with the traditional microfluidic chip made of PDMS, the microfluidic chip in the present invention is made of glass, and when the organic solvent is introduced, the chip will not swell. Therefore, continuous flow reaction can be carried out in the channel to mass produce polymer nanoparticles.
5)合成的聚合物纳米粒子还可以表面功能化,以便后期生物功能化等应用。5) The synthesized polymer nanoparticles can also be surface functionalized for later applications such as biofunctionalization.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为本发明所使用的装置图;FIG1 is a diagram of an apparatus used in the present invention;
图2为本发明三维微流控混合芯片结构示意图;FIG2 is a schematic diagram of the structure of a three-dimensional microfluidic hybrid chip according to the present invention;
图3为实施例1所得聚合物纳米颗粒的吸收光谱图;FIG3 is an absorption spectrum of polymer nanoparticles obtained in Example 1;
图4为实施例1所得聚合物量子点荧光探针的荧光发射光谱图;FIG4 is a fluorescence emission spectrum of the polymer quantum dot fluorescent probe obtained in Example 1;
图5为实施例1所得聚合物量子点PFO荧光探针的透射电子显微镜(TEM)照片图;FIG5 is a transmission electron microscope (TEM) photograph of the polymer quantum dot PFO fluorescent probe obtained in Example 1;
图6为实施例2所得聚合物量子点F8BT荧光探针的透射电子显微镜(TEM)照片图;FIG6 is a transmission electron microscope (TEM) photograph of the polymer quantum dot F8BT fluorescent probe obtained in Example 2;
图7为实施例3所得聚合物量子点MEH-PPV荧光探针的透射电子显微镜(TEM)照片图;FIG7 is a transmission electron microscope (TEM) photograph of the polymer quantum dot MEH-PPV fluorescent probe obtained in Example 3;
图8为对比例1所得聚合物量子点PFO荧光探针的透射电子显微镜(TEM)照片图;FIG8 is a transmission electron microscope (TEM) photograph of the polymer quantum dot PFO fluorescent probe obtained in Comparative Example 1;
图9为对比例2所得聚合物量子点F8BT荧光探针的透射电子显微镜(TEM)照片图。FIG. 9 is a transmission electron microscope (TEM) photograph of the polymer quantum dot F8BT fluorescent probe obtained in Comparative Example 2.
具体实施方式DETAILED DESCRIPTION
为使本发明实施例的目的、技术方案和优点更加清楚,下面将对本发明实施例的技术方案进行清楚、完整的描述。显然,所描述的实施例是本发明的一部分实施例,而不是全部的实施例。基于所描述的本发明的实施例,本领域普通技术人员在无需创造性劳动的前提下所获得的所有其他实施例,都属于本发明的保护范围。In order to make the purpose, technical solution and advantages of the embodiment of the present invention clearer, the technical solution of the embodiment of the present invention will be clearly and completely described below. Obviously, the described embodiment is a part of the embodiment of the present invention, not all the embodiments. Based on the described embodiment of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work belong to the protection scope of the present invention.
在本文中所披露的范围的端点和任何值都不限于该精确的范围或值,这些范围或值应当理解为包含接近这些范围或值的值。对于数值范围来说,各个范围的端点值之间、各个范围的端点值和单独的点值之间,以及单独的点值之间可以彼此组合而得到一个或多个新的数值范围,这些数值范围应被视为在本文中具体公开。The endpoints and any values of the ranges disclosed in this article are not limited to the precise ranges or values, and these ranges or values should be understood to include values close to these ranges or values. For numerical ranges, the endpoint values of each range, the endpoint values of each range and the individual point values, and the individual point values can be combined with each other to obtain one or more new numerical ranges, which should be considered as specifically disclosed in this article.
除非另作定义,本公开所使用的技术术语或者科学术语应当为本发明所属领域内有一般技能的人士所理解的通常意义。Unless otherwise defined, technical or scientific terms used in the present disclosure shall have the common meanings understood by one of ordinary skill in the art to which the present invention belongs.
本发明提供了一种超小粒径聚合物纳米颗粒的制备方法:具体包括:The present invention provides a method for preparing ultra-small particle size polymer nanoparticles, which specifically comprises:
1)将聚合物粉末溶解在良溶剂中,得聚合物良溶剂前驱体溶液A。1) Dissolve the polymer powder in a good solvent to obtain a polymer good solvent precursor solution A.
2) 溶液A按固定比例稀释,加入一定比例的两亲性试剂使其表面功能化,得溶液B。2) Solution A is diluted at a fixed ratio, and a certain proportion of amphiphilic reagent is added to functionalize its surface to obtain solution B.
3)把溶液B和其不良溶剂C分别放置在注射泵上,按照一定流速将两相溶液注射至三维微混合芯片中,接着将混合后的液体流入烧瓶中。最后将烧瓶中的胶体溶液通过旋蒸除去良溶剂得到聚合物纳米颗粒溶液。3) Place solution B and its poor solvent C on the syringe pumps respectively, inject the two-phase solution into the three-dimensional micro-mixing chip at a certain flow rate, and then flow the mixed liquid into the flask. Finally, the colloidal solution in the flask is evaporated to remove the good solvent to obtain a polymer nanoparticle solution.
下面通过实施例对本发明作进一步说明。The present invention will be further described below by way of examples.
以下实施例均采用附图1所示的装置来完成,图中,两台注射泵1通过管路2分别连接三维微流控混合芯片3的两进样口4;三维微流控混合芯片3的出样口5通过管路2连接储物瓶6。The following embodiments are all completed using the device shown in Figure 1. In the figure, two injection pumps 1 are respectively connected to two sample inlets 4 of a three-dimensional microfluidic mixing chip 3 through pipelines 2; the sample outlet 5 of the three-dimensional microfluidic mixing chip 3 is connected to a storage bottle 6 through pipelines 2.
附图2为三维微流控混合芯片3的结构示意图,图中的a图为三维微流控混合芯片外形图;b图为微流控混合芯片中混合单元的局部结构图,c图为实际混合图,d图为芯片局部俯视图。Figure 2 is a schematic diagram of the structure of a three-dimensional microfluidic mixing chip 3, in which Figure a is an appearance diagram of the three-dimensional microfluidic mixing chip; Figure b is a local structural diagram of the mixing unit in the microfluidic mixing chip, Figure c is an actual mixing diagram, and Figure d is a local top view of the chip.
实施例1Example 1
称量5 mg PFO溶于5 mL四氢呋喃中,配置成1 mg/mL的溶液,再将其用四氢呋喃稀释至50 ug/mL,用注射器取1 mL该溶液,放置于一注射泵上。另一个注射泵上放置2 mL超纯水。两个注射泵流速分别为:200 uL/min、400 uL/min。两个注射泵分别连接三维微流控混合芯片入口,开始反应,在出口将产物接出。Weigh 5 mg of PFO and dissolve it in 5 mL of tetrahydrofuran to make a 1 mg/mL solution, then dilute it with tetrahydrofuran to 50 ug/mL, take 1 mL of the solution with a syringe and place it on a syringe pump. Place 2 mL of ultrapure water on another syringe pump. The flow rates of the two syringe pumps are 200 uL/min and 400 uL/min respectively. The two syringe pumps are connected to the inlet of the three-dimensional microfluidic mixing chip, start the reaction, and take out the product at the outlet.
再将产物通过旋蒸,将四氢呋喃溶剂蒸干后得到PFO半导体聚合物量子点。所得纳米颗粒溶液吸光度如图3所示,荧光发射图如图4所示,透射电镜如图5所示,图5 (a)本实施例中PFO纳米颗粒TEM图;(b)PFO纳米颗粒粒径尺寸分布图;其平均粒径为1.96 nm。The product was then subjected to rotary evaporation to evaporate the tetrahydrofuran solvent to obtain PFO semiconductor polymer quantum dots. The absorbance of the obtained nanoparticle solution is shown in FIG3 , the fluorescence emission graph is shown in FIG4 , and the transmission electron micrograph is shown in FIG5 , FIG5 (a) TEM image of PFO nanoparticles in this embodiment; (b) PFO nanoparticle size distribution diagram; the average particle size is 1.96 nm.
实施例2Example 2
称量5 mg F8BT溶于5 mL四氢呋喃中,配置成1 mg/mL的溶液,再将其用四氢呋喃稀释至50 ug/mL,用注射器取1 mL该溶液,放置于一注射泵上。另一个注射泵上放置2 mL超纯水。两个注射泵流速分别为:210 uL/min、450 uL/min。两个注射泵分别连接芯片入口,开始反应,在出口将产物接出。Weigh 5 mg of F8BT and dissolve it in 5 mL of tetrahydrofuran to make a 1 mg/mL solution, then dilute it with tetrahydrofuran to 50 ug/mL, take 1 mL of the solution with a syringe and place it on a syringe pump. Place 2 mL of ultrapure water on another syringe pump. The flow rates of the two syringe pumps are: 210 uL/min and 450 uL/min respectively. Connect the two syringe pumps to the chip inlet, start the reaction, and take out the product at the outlet.
再将产物通过旋蒸,将四氢呋喃溶剂蒸干后得到F8BT半导体聚合物量子点,透射电镜如图6所示,图6(a)本实施例中F8BT纳米颗粒TEM图;(b)F8BT纳米颗粒粒径尺寸分布图;其平均粒径为1.74 nm。The product was then subjected to rotary evaporation to evaporate the tetrahydrofuran solvent to obtain F8BT semiconductor polymer quantum dots. The transmission electron microscopy is shown in Figure 6, where (a) is a TEM image of F8BT nanoparticles in this embodiment; (b) is a particle size distribution diagram of F8BT nanoparticles; the average particle size is 1.74 nm.
实施例3Example 3
称量5 mg MEH-PPV溶于5 mL四氢呋喃中,配置成1 mg/mL的溶液,再将其用四氢呋喃稀释至30 ug/mL,并加入终浓度为10 ug/mL两亲性聚合物PSMA,用注射器取1 mL该溶液,放置于一注射泵上。另一个注射泵上放置2 mL超纯水。注射泵流速分别为:263uL/min、500uL/min。两个注射泵分别连接芯片入口,开始反应,在出口将产物接出。Weigh 5 mg of MEH-PPV and dissolve it in 5 mL of tetrahydrofuran to make a 1 mg/mL solution, then dilute it with tetrahydrofuran to 30 ug/mL, and add the amphiphilic polymer PSMA with a final concentration of 10 ug/mL. Take 1 mL of the solution with a syringe and place it on a syringe pump. Place 2 mL of ultrapure water on another syringe pump. The flow rates of the syringe pumps are: 263uL/min and 500uL/min. The two syringe pumps are connected to the chip inlet, start the reaction, and take out the product at the outlet.
再将产物通过旋蒸,将乙醇溶剂蒸干后得到MEH-PPV半导体聚合物量子点。透射电镜如图7所示,图7(a)本实施例中MEH-PPV纳米颗粒TEM图;(b)MEH-PPV纳米颗粒粒径尺寸分布图;其平均粒径为2.06 nm。The product was then subjected to rotary evaporation to evaporate the ethanol solvent to obtain MEH-PPV semiconductor polymer quantum dots. Transmission electron microscopy is shown in Figure 7, where (a) is a TEM image of MEH-PPV nanoparticles in this embodiment; (b) is a particle size distribution diagram of MEH-PPV nanoparticles; the average particle size is 2.06 nm.
对比例1Comparative Example 1
称量5 mg PFO溶于5 mL四氢呋喃中,配置成1 mg/mL的溶液,再将其用四氢呋喃稀释至50 ug/mL,用注射器取1 mL该溶液,放置在玻璃瓶中。另一个注射器中取2 mL超纯水。将超纯水注入装有聚合物溶液的玻璃瓶中,超声1min,得到产物。Weigh 5 mg of PFO and dissolve it in 5 mL of tetrahydrofuran to make a 1 mg/mL solution, then dilute it with tetrahydrofuran to 50 ug/mL, take 1 mL of the solution with a syringe and place it in a glass bottle. Take 2 mL of ultrapure water in another syringe. Pour the ultrapure water into the glass bottle containing the polymer solution and ultrasonicate for 1 minute to obtain the product.
再将产物通过旋蒸,将四氢呋喃溶剂蒸干后得到PFO半导体聚合物量子点。透射电镜如图8所示。可以明显发现,使用本发明中的微流控装置合成的纳米颗粒粒径远小于普通方法合成的半导体聚合物纳米颗粒的粒径,并且单分散性更好。The product is then subjected to rotary evaporation to evaporate the tetrahydrofuran solvent to obtain PFO semiconductor polymer quantum dots. Transmission electron microscopy is shown in Figure 8. It can be clearly found that the particle size of the nanoparticles synthesized using the microfluidic device of the present invention is much smaller than the particle size of the semiconductor polymer nanoparticles synthesized by the conventional method, and the monodispersity is better.
对比例2Comparative Example 2
称量5 mg F8BT溶于5 mL四氢呋喃中,配置成1 mg/mL的溶液,再将其用四氢呋喃稀释至50 ug/mL,用注射器取1 mL该溶液,放置于一注射泵上。另一个注射泵上放置2 mL超纯水。两个注射泵流速分别为:50 uL/min、250 uL/min。两个注射泵分别连接芯片入口,开始反应,在出口将产物接出。Weigh 5 mg of F8BT and dissolve it in 5 mL of tetrahydrofuran to make a 1 mg/mL solution, then dilute it with tetrahydrofuran to 50 ug/mL, take 1 mL of the solution with a syringe and place it on a syringe pump. Place 2 mL of ultrapure water on another syringe pump. The flow rates of the two syringe pumps are 50 uL/min and 250 uL/min respectively. Connect the two syringe pumps to the chip inlet, start the reaction, and take out the product at the outlet.
再将产物通过旋蒸,将四氢呋喃溶剂蒸干后得到F8BT半导体聚合物量子点。透射电镜如图9所示。可以明显发现,使用本发明中的流速范围合成的纳米颗粒粒径远小于其他流速合成的半导体聚合物纳米颗粒的粒径,并且单分散性更好。The product was then subjected to rotary evaporation to evaporate the tetrahydrofuran solvent to obtain F8BT semiconductor polymer quantum dots. The transmission electron microscope is shown in Figure 9. It can be clearly found that the particle size of the nanoparticles synthesized using the flow rate range of the present invention is much smaller than the particle size of the semiconductor polymer nanoparticles synthesized at other flow rates, and the monodispersity is better.
以上详细描述了本发明的优选实施方式,但是,本发明并不限于上述实施方式中的具体细节,在本发明的技术构思范围内,可以对本发明的技术方案进行多种简单变型,这些简单变型均属于本发明的保护范围。The preferred embodiments of the present invention are described in detail above. However, the present invention is not limited to the specific details in the above embodiments. Within the technical concept of the present invention, a variety of simple modifications can be made to the technical solution of the present invention, and these simple modifications all belong to the protection scope of the present invention.
另外需要说明的是,在上述具体实施方式中所描述的各个具体技术特征,在不矛盾的情况下,可以通过任何合适的方式进行组合,为了避免不必要的重复,本发明对各种可能的组合方式不再另行说明。It should also be noted that the various specific technical features described in the above specific embodiments can be combined in any suitable manner without contradiction. In order to avoid unnecessary repetition, the present invention will not further describe various possible combinations.
此外,本发明的各种不同的实施方式之间也可以进行任意组合,只要其不违背本发明的思想,其同样应当视为本发明所公开的内容。In addition, various embodiments of the present invention may be arbitrarily combined, and as long as they do not violate the concept of the present invention, they should also be regarded as the contents disclosed by the present invention.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210883077.2A CN115382476B (en) | 2022-07-26 | 2022-07-26 | A method for preparing ultra-small particle size polymer nanoparticles |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210883077.2A CN115382476B (en) | 2022-07-26 | 2022-07-26 | A method for preparing ultra-small particle size polymer nanoparticles |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115382476A CN115382476A (en) | 2022-11-25 |
CN115382476B true CN115382476B (en) | 2024-10-22 |
Family
ID=84115954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210883077.2A Active CN115382476B (en) | 2022-07-26 | 2022-07-26 | A method for preparing ultra-small particle size polymer nanoparticles |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115382476B (en) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2009270849B2 (en) * | 2008-07-17 | 2013-11-21 | Micell Technologies, Inc. | Drug delivery medical device |
US20130017265A1 (en) * | 2009-12-16 | 2013-01-17 | Massachusetts Institute Of Technology | Particles for multiple agent delivery |
EP3572072A1 (en) * | 2011-01-24 | 2019-11-27 | Anterios, Inc. | Nanoparticle compositions |
US9597418B2 (en) * | 2014-03-18 | 2017-03-21 | Universite De Nantes | Magnetic and fluorescent reverse nanoassemblies |
EP3828272B9 (en) * | 2016-03-18 | 2023-12-27 | Caris Science, Inc. | Method of enrichment of oligonucleotide probes |
US20200101014A1 (en) * | 2017-04-03 | 2020-04-02 | Wisconsin Alumni Research Foundation | Stable Theranostic and Therapeutic Nanoemulsions Using Triphilic Semifluorinated Amphiphiles |
JP2021523151A (en) * | 2018-05-11 | 2021-09-02 | ホスホレックス、インコーポレイテッド | Microparticles and nanoparticles with negative surface charge |
WO2020243234A1 (en) * | 2019-05-29 | 2020-12-03 | Saudi Arabian Oil Company | Flow synthesis of polymer nanoparticles |
SG10201905946YA (en) * | 2019-06-26 | 2021-01-28 | Nat Univ Singapore | Systems and Methods for Fabricating Nanoparticles |
EP3838266A1 (en) * | 2019-12-20 | 2021-06-23 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Microfluidic production of biofunctionalized giant unilamellar vesicles for targeted intracellular cargo delivery |
CN111214438A (en) * | 2020-02-14 | 2020-06-02 | 浙江工业大学 | A method for preparing doxorubicin-loaded polymer micelles of different sizes |
-
2022
- 2022-07-26 CN CN202210883077.2A patent/CN115382476B/en active Active
Non-Patent Citations (2)
Title |
---|
continuous preparation of semiconducting polymer nanoparticles with varied sizes for online flurenscence sensing via a laser-tailored 3D mocrofluid chip;ruixuan hu;analytical chemistry;20230629;全文 * |
三维微混合芯片连续可控合成半导体聚合物纳米颗粒及其荧光传感分析研究;胡锐宣;中国优秀硕士学位论文全文数据库(电子期刊)工程I辑;20230509;全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN115382476A (en) | 2022-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gallei | Functional Polymer Opals and Porous Materials by Shear‐Induced Assembly of Tailor‐Made Particles | |
Kang et al. | Review of conjugated polymer nanoparticles: from formulation to applications | |
Kang et al. | Mass production of highly monodisperse polymeric nanoparticles by parallel flow focusing system | |
Stolzenburg et al. | Microfluidic synthesis of metal oxide nanoparticles via the nonaqueous method | |
CN114025871A (en) | Systems and methods for making nanoparticles | |
Ling et al. | Synthesis and characteristics of silica nano-particles using modified sol–gel method in microreactor | |
US20090062407A1 (en) | Method and apparatus for producing micro emulsions | |
Chen et al. | Recent advances in mixing-induced nanoprecipitation: from creating complex nanostructures to emerging applications beyond biomedicine | |
CN104262645A (en) | A method for preparing narrow-distribution polymer micro-nanospheres with controllable particle size | |
Wong et al. | Dynamic metastable polymersomes enable continuous flow manufacturing | |
CN115382476B (en) | A method for preparing ultra-small particle size polymer nanoparticles | |
Piacentini et al. | Continuous production of PVA-based hydrogel nanoparticles by membrane nanoprecipitation | |
CN113398853A (en) | Nano quantum dot low-temperature synthesis device and method and application of nano quantum dot low-temperature synthesis device in synthesis of sulfur indium silver quantum dots | |
Song et al. | Recent advances in microfluidic fiber‐spinning chemistry | |
Huang et al. | Facile preparation of size-controlled gold nanoparticles using versatile and end-functionalized thioether polymer ligands | |
CN113773521B (en) | Method for preparing emulsion and polymer particles with size less than 10 nanometers based on droplet self-breaking phenomenon | |
KR101654790B1 (en) | Fabrication Method for Multicompartmental Microparticles | |
D'Amato et al. | Chemical synthesis of polyphenylacetylene nanospheres with controlled dimensions for photonic crystals | |
CN102838760B (en) | Preparation method for polymer nanoparticles | |
Huang et al. | Polyaniline hollow microspheres constructed with their own self‐assembled nanofibers | |
Martins et al. | Microfluidics as a Tool for the Synthesis of Advanced Drug Delivery Systems | |
Shi et al. | Dynamic control over hierarchically dendritic architectures of simple heterogenous monomers by living supramolecular assembly | |
Ling et al. | Investigating the effect of nonionic surfactant on the silica nanoparticles formation and morphology in a microfluidic reactor | |
KR102522521B1 (en) | ROS-responsive drug delivery nanoparticles produced by a device for producing nanoparticles | |
CN114950582B (en) | Microfluidic chip device for synthesizing nano particles and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |